a.clinicTalk to a doctor
Book a consultation
Randomised trialsWhole body

Lower risk of serious kidney disease

Published in
Lancet Diabetes Endocrinol 2014
People studied
4,831

In a trial of 5,145 adults with type 2 diabetes, a weight-loss programme went with about 31% lower risk of kidney disease in the highest risk category over 8 years.

Checked against
PubMed 25127483
Published in
Lancet Diabetes Endocrinol 2014
Last checked
30 October 2026

Key takeaway

Look AHEAD randomly assigned 5,145 adults with type 2 diabetes and overweight or obesity to a lifestyle programme aimed at weight loss, or to diabetes support and education. Over a median of 8 years, chronic kidney disease in the highest risk category developed less often in the programme group, a 31% lower risk. Part of this went with lower weight, blood sugar and blood pressure, and there were no kidney safety concerns.

At a glance

Type of study
secondary analysis of a randomised trial
People studied
4,831
How long
about 8 years (median)
Compared with
a diabetes support and education group
Main result
About 31% lower risk of kidney disease in the highest risk category over 8 years.
Strength of evidence
Randomised trials

What this study does not show

The kidney outcome was defined after the trial had started, as one of many outcomes, so it needs confirming. Everyone in the trial had type 2 diabetes.

Results from studies in groups of people, mostly in diet and movement programmes. They cannot be promised to any one person. This information is educational and does not replace a consultation with a doctor.

The next step is a conversation, not a decision

A licensed doctor decides whether any treatment is right for you. The answer can also be no treatment.

  1. 1

    You fill in a short form

  2. 2

    We call you within 24 hours

  3. 3

    A paid 20-minute video consultation with a doctor

  4. 4

    The doctor goes through your options and decides what is right for you

Would you like to talk it through with a doctor?

Book a consultation